Cambridge, Canada

Michael John Byrne

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Wave Life Sciences Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael John Byrne. Retrieved from https://idiyas.com/inventor/michael-john-byrne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael John Byrne: Innovator in Oligonucleotide Compositions

Introduction

Michael John Byrne is a notable inventor based in Cambridge, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide compositions. His work has implications for various applications in medicine and research.

Latest Patents

Michael John Byrne holds a patent for "Oligonucleotide Compositions and Methods of Use Thereof." This patent represents his innovative approach to utilizing oligonucleotides in various applications, showcasing his expertise in the field.

Career Highlights

Byrne is currently employed at Wave Life Sciences Ltd., a company focused on developing transformative medicines for patients with genetic diseases. His role at the company allows him to apply his knowledge and skills in a collaborative environment, driving forward the company's mission.

Collaborations

Throughout his career, Michael has worked alongside talented individuals such as Lankai Guo and Vinod Vathipadiekal. These collaborations have enriched his research and contributed to the advancement of their shared goals in biotechnology.

Conclusion

Michael John Byrne is a distinguished inventor whose work in oligonucleotide compositions has the potential to impact the field of biotechnology significantly. His contributions and collaborations continue to pave the way for innovative solutions in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…